Business and continuity of operations: Care of the critically ill and injured during pandemics and disasters: CHEST consensus statement

Chest

Volumn 146, Issue , 2014, Pages e103S-e117S

  Tosh, Pritish K ^a   Feldman, Henry ^b,c   Christian, Michael D ^d   Devereaux, Asha V ^e   Kissoon, Niranjan ^f   Dichter, Jeffrey R ^g,h  

^a MAYO CLINIC   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MOUNT SINAI HOSPITAL   (Canada)

^e SHARP HEALTHCARE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g Allina Health Laboratories   (United States)

^h AURORA HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADENOSINE; AMIODARONE; ATROPINE; AZITHROMYCIN; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DIGOXIN; DILTIAZEM; DOXYCYCLINE HYCLATE; FENTANYL; FLUCONAZOLE; HYDROMORPHONE; KETOROLAC TROMETAMOL; LEVOFLOXACIN; MEROPENEM; METHYLPREDNISOLONE ACETATE; METRONIDAZOLE; NAFCILLIN; OSELTAMIVIR; OXYCODONE; PREDNISONE; SULTAMICILLIN; UNINDEXED DRUG; VANCOMYCIN;

ARTICLE; CONSENSUS; CRITICALLY ILL PATIENT; DELPHI STUDY; DISASTER PLANNING; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INFORMATION TECHNOLOGY; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MEDICAL LITERATURE; PANDEMIC; PATIENT CARE; CRITICAL ILLNESS; DISASTER; INTENSIVE CARE; ORGANIZATION AND MANAGEMENT; UNITED STATES; WOUNDS AND INJURIES;

CONSENSUS; CRITICAL CARE; CRITICAL ILLNESS; DISASTERS; HEALTH RESOURCES; HUMANS; PANDEMICS; UNITED STATES; WOUNDS AND INJURIES;

EID: 84908495063     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0739     Document Type: Article

References (81)

1. King M.A., Niven AS, Beninati W, et al; on behalf of the Task Force for Mass Critical Care. Evacuation of the ICU: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014;146(4-suppl):e44S-e60S.
2. Hick JL, Einav S, Hanfling D, et al; on behalf of the Task Force for Mass Critical Care. Surge capacity principles: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014;146(4-suppl):e1S-e16S.
3. Einav S, Hick JL, Hanfling D, et al; Task Force for Mass Critical Care. Surge capacity logistics: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014;146(-4suppl):e17S-e43S.
4. Dichter JR, Kanter RK, Dries D, et al; on behalf of the Task Force for Mass Critical Care. System level planning, coordination, and communication: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014;146(4-suppl):e87S-e102S.
5. Christian MD, Sprung CL, King MA, et al; on behalf of the Task Force for Mass Critical Care. Triage: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014;146(4-suppl):e61S-e74S.
6. Blos MF, Wee HM, Yang J. Analysing the external supply chain risk driver competitiveness: a risk mitigation framework and business continuity plan. J Bus Continuity Emerg Plann. 2010;4(4):368-374.
7. Provisional observations on drug product shortages: effects, causes, and potential solutions. Am J Health Syst Pharm. 2002;59(22):2173-2182.
8. Bush H. Supply chain. Reliance on overseas manufacturers worries supply chain experts. Hosp Health Netw. 2011;85(7):13.
9. Mirtallo JM, Holcombe B, Kochevar M, Guenter P. Parenteral nutrition product shortages: the A.S.P.E.N. strategy. Nutr Clin Pract. 2012;27(3):385-391.
10. Rollins G. Supply chain. Flu survey shows significant cracks in supply chain. Hosp Health Netw. 2010;84(7):10.
11. Page D. Will your IT system be ready when disaster hits? Hosp Health Netw. 2011;85(10):43-44., 2.
12. Callaway DW, Peabody CR, Hoffman A, et al. Disaster mobile health technology: lessons from Haiti. Prehosp Disaster Med. 2012;27(2):148-152.
13. Levy G, Blumberg N, Kreiss Y, Ash N, Merin O. Application of information technology within a field hospital deployment following the January 2010 Haiti earthquake disaster. J Am Med Inform Assoc. 2010;17(6):626-630.
14. Ornelas J, Dichter JR, Devereaux AV, Kissoon N, Livinski A, Christian MD; on behalf of the Task Force for Mass Critical Care. Methodology: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014;146(4-suppl):35S-41S.
15. Duffin J. Canadian drug shortage: recent history of a mystery. CMAJ. 2012;184(8): 1000.
16. Fox E, Tyler LS. Recent trends in drug shortages: an update from the 2003 report. Am J Health Syst Pharm. 2009;66(9):798-800.
17. Fox ER, Tyler LS. Managing drug shortages: seven years' experience at one health system. Am J Health Syst Pharm. 2003;60(3):245-253.
18. Mayer DK. Anatomy of a drug shortage. Clin J Oncol Nurs. 2012;16(2):107-108.
19. Griffith MM, Gross AE, Sutton SH, et al. The impact of anti-infective drug shortages on hospitals in the United States: trends and causes. Clin Infect Dis. 2012;54(5):684-691.
20. Guda NM, Noonan M, Kreiner MJ, Partington S, Vakil N. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage? Am J Gastroenterol. 2004;99(7):1233-1237.
21. Larkin H. Drug shortage may be worst in 30 years. Hosp Health Netw. 2011;85(2):28-30., 32.
22. Mitka M. FDA, US hospital and pharmacy groups report drug shortages a growing problem. JAMA. 2011;306(10):1069-1070.
23. Medline receives force majeure notice from Hong Ray Enterprises. Medline website. http://www.medline.com/jump/category-content/media-room/press-releases/2008/07/medline-receives-force-majeure-notice-from-hong-ray-enterprises. Accessed August 17, 2013.
24. Hess C. Olympics add to shortage of medical exam gloves. The Milwaukee Business Journal. Aug 3, 2008.
25. Alkire M. Tariff s on Chinese medical products could pose problems for supply chain. Mater Manag Health Care. 2010;19(1):32.
26. Paxton M. Current challenges with supply-chain integrity and the threat to the quality of marketed drugs. Clin Pharmacol Ther. 2011;89(2):316-319.
27. Centers for Disease Control and Prevention (CDC). Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy - United States, 2012. MMWR Morb Mortal Wkly Rep. 2012;61(41):839-842.
28. Hedlund KD, Coyne DP, Sanford DM, Huddelson J. The heparin recall of 2008. Perfusion. 2013;28(1):61-65.
29. Connelly P, Quinn BP. Manufacturing decline yields drug shortages. Science. 2011;333(6039):156-157.
30. Eggertson L. Drug shortage registry under discussion. CMAJ. 2011;183(10):E637-E638.
31. Gainsbury S. Drug shortage looms as pound falls. Health Serv J. 2009;119(6140):4-5.
32. Gehrett BK. A prescription for drug shortages. JAMA. 2012;307(2):153-154.
33. Inglis T. National drug shortages. Am J Nurs. 2002;102(7):11.
34. Wilson D. Deepening drug shortages. Health Aff (Millwood). 2012;31(2):263-266.
35. Novo Nordisk Denmark. Pharmaceutical-technology.com website. http://www.pharmaceutical-technology.com/projects/novo/. Accessed August 3, 2014.
36. Gomella LG. Can anyone spare a little indigo carmine? The drug shortage crisis. Can J Urol. 2012;19(3):6238.
37. Griffith MM, Pentoney Z, Scheetz MH. Antimicrobial drug shortages: a crisis amidst the epidemic and the need for antimicrobial stewardship efforts to lessen the effects. Pharmacotherapy. 2012;32(8):665-667.
38. Mendez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo BJ. Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections. Pharmacotherapy. 2006;26(1):61-67.
39. Mirtallo JM. The drug shortage crisis. JPEN J Parenter Enteral Nutr. 2011;35(4):433.
40. Plüss-Suard C, Pannatier A, Ruffieux C, Kronenberg A, Mühlemann K, Zanetti G. Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis. Antimicrob Agents Chemother. 2012;56(2):989-994.
41. Roberts R, Ruthazer R, Chi A, et al. Impact of a national propofol shortage on duration of mechanical ventilation at an academic medical center. Crit Care Med. 2012;40(2):406-411.
42. Tanne JH. US drug shortages are set to reach record high in 2011, report says. BMJ. 2011;343:d8307.
43. Tyler LS, Fox ER, Caravati EM. The challenge of drug shortages for emergency medicine. Ann Emerg Med. 2002;40(6):598-602.
44. American Society of Health-System Pharmacists website. http://www.ashp.org. Accessed November 19, 2013.
45. Baumer AM, Clark AM, Witmer DR, Geize SB, Vermeulen LC, Deffenbaugh JH. National survey of the impact of drug shortages in acute care hospitals. Am J Health Syst Pharm. 2004;61(19):2015-2022.
46. Carter D. Drug shortage crisis affects patients and nurses. Am J Nurs. 2011;111(11):14.
47. Corrigan M, Kirby DF. Impact of a national shortage of sterile ethanol on a home parenteral nutrition practice: a case series. JPEN J Parenter Enteral Nutr. 2012;36(4):476-480.
48. Holcombe B. Parenteral nutrition product shortages: impact on safety. JPEN J Parenter Enteral Nutr. 2012;36(suppl 2):44S-47S.
49. Dorsey ER, Thompson JP, Dayoub EJ, George B, Saubermann LA, Holloway RG. Selegiline shortage: causes and costs of a generic drug shortage. Neurology. 2009;73(3):213-217.
50. Ferrández O, Mateu-de Antonio J, Grau S. Effects of antimicrobial drug shortages. Am J Health Syst Pharm. 2005;62(14):1444.
51. Kaakeh R, Sweet BV, Reilly C, et al. Impact of drug shortages on US health systems. Am J Health Syst Pharm. 2011;68(19):1811-1819.
52. A Review of FDA's Approach to Medical Product Shortages. Washington, DC : US Department of Health and Human Services. 2011.
53. Bureau of Industry and Security Office of Technology Evaluation. Reliance on Foreign Sourcing the Healthcare and Public Health (HPH) Sector: Pharmaceuticals, Medical Devices, and Surgical Equipment. Washington, DC : US Department of Commerce. 2011.
54. Fox ER, Birt A, James KB, Kokko H, Salverson S, Soflin DL; ASHP Expert Panel on Drug Product Shortages. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health Syst Pharm. 2009;66(15):1399-1406.
55. Bilyk C. Don't break the chain: importance of supply chain management in the operating room setting. Can Oper Room Nurs J. 2008;26(3):21-22, 30-34.
56. DeJohn P. A small ASC's automated supply chain. OR Manager. 2008;24(11):26-27., 29.
57. DeJohn P. Best ASC supply chain practices. OR Manager. 2011;27(1):25-27., 29.
58. Fox ER, Tyler LS. One pharmacy's approach to managing drug shortages. Am J Health Syst Pharm. 2003;60(1):27, 31.
59. Griffith MM, Patel JA, Sutton SH, et al. Prospective approach to managing antimicrobial drug shortages. Infect Control Hosp Epidemiol. 2012;33(7):745-752.
60. Revere L, Black K, Zalila F. RFIDs can improve the patient care supply chain. Hosp Top. 2010;88(1):26-31.
61. Shih SC, Rivers PA, Hsu HY. Strategic information technology alliances for eff ective health-care supply chain management. Health Serv Manage Res. 2009; 22(3):140-150.
62. Bayram JD, Sauer LM, Catlett C, et al. Critical resources for hospital surge capacity: an expert consensus panel. PLoS Curr. 2013;5:5.
63. Manolakis M. Ethical integrity in managing drug shortages. Am J Health Syst Pharm. 2012;69(1):17.
64. Barlas S. FDA's new authority on drug shortages. P&T. 2012;37(7):379.
65. Born K. Time and money: an analysis of the legislative efforts to address the prescription drug shortage crisis in America. J Leg Med. 2012;33(2):235-251.
66. Burns K. Presidential order targets drug shortages: FDA report analyzes problem, identifies action steps for agency. J Am Vet Med Assoc. 2011;239(12):1522-1523.
67. Devi S. US drug shortages could continue for years. Lancet. 2012;379(9820):990-991.
68. Hampton T. Experts look for ways to lessen impact of drug shortages and discontinuations. JAMA. 2007;298(7):727-728.
69. Somberg JC. Securing the US pharmaceutical supply. Am J Ther. 2008;15(3):197.
70. Thompson CA. Senator proposes drug shortages law. Am J Health Syst Pharm. 2011;68(6):461.
71. Uppal A, Evans L, Chitkara N, et al. In search of the silver lining: the impact of superstorm Sandy on Bellevue Hospital. Ann Am Thorac Soc. 2013;10(2):135-142.
72. Case T, Morrison C, Vuylsteke A. The clinical application of mobile technology to disaster medicine. Prehosp Disaster Med. 2012;27(5):473-480.
73. Chan TC, Killeen J, Griswold W, Lenert L. Information technology and emergency medical care during disasters. Acad Emerg Med. 2004;11(11):1229-1236.
74. Nagata T, Halamka J, Himeno S, Himeno A, Kennochi H, Hashizume M. Using a cloud-based electronic health record during disaster response: a case study in Fukushima, March 2011. Prehosp Disaster Med. 2013;28(4):383-387.
75. Chan TC, Griswold WG, Buono C, et al. Impact of wireless electronic medical record system on the quality of patient documentation by emergency field responders during a disaster mass-casualty exercise. Prehosp Disaster Med. 2011;26(4):268-275.
76. Crowe IR, Naguib RN. The deployment of information systems and information technology in field hospitals. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:4423-4426.
77. Demers G, Kahn C, Johansson P, et al. Secure scalable disaster electronic medical record and tracking system. Prehosp Disaster Med. 2013;28(5):498-501.
78. Choi J, Yoo S, Park H, Chun J. MobileMed: a PDA-based mobile clinical information system. IEEE Trans Inf Technol Biomed. 2006;10(3):627-635.
79. Ornstein C. Why hospital generators keep failing. ProPublica; 2012. http://www.thewire.com/national/2012/10/why-hospital-generators-keep-failing/58569/. Accessed August 3, 2014.
80. Alper A, Kupferman S; New York City Emergency Response Task Force. Enhancing New York City's Emergency Preparedness: A Report to Mayor Michael R. Bloomberg. 2003. http://www.nyc.gov/html/om/pdf/emtaskforcefinal102803.pdf. Accessed August 3, 2014
81. Lau C, Wongsurawat W. Crisis management: Western Digital's 46-day recovery from the 2011 flood disaster in Thailand. Strategy & Leadership. 2013;41(1):34-38.